Gardner, K., Delicou, S., El Rassi, F., Andemariam, B., Abboud, M. R., Kanter, J., … Eisenberger, A. (2025). Etavopivat reduces vaso-occlusive crisis incidence in sickle cell disease: HIBISCUS 2 week 52 results. In BRITISH JOURNAL OF HAEMATOLOGY (Vol. 206).

Gardner, Kate, Sophia Delicou, Fuad El Rassi, Biree Andemariam, Miguel R. Abboud, Julie Kanter, Marilyn J. Telen, et al. “Etavopivat reduces vaso-occlusive crisis incidence in sickle cell disease: HIBISCUS 2 week 52 results.” In BRITISH JOURNAL OF HAEMATOLOGY, Vol. 206, 2025.

Gardner K, Delicou S, El Rassi F, Andemariam B, Abboud MR, Kanter J, et al. Etavopivat reduces vaso-occlusive crisis incidence in sickle cell disease: HIBISCUS 2 week 52 results. In: BRITISH JOURNAL OF HAEMATOLOGY. 2025.

Gardner, Kate, et al. “Etavopivat reduces vaso-occlusive crisis incidence in sickle cell disease: HIBISCUS 2 week 52 results.” BRITISH JOURNAL OF HAEMATOLOGY, vol. 206, 2025.

Gardner K, Delicou S, El Rassi F, Andemariam B, Abboud MR, Kanter J, Telen MJ, Githanga J, Inati A, Idris I, Navani S, Wu E, Eisenberger A. Etavopivat reduces vaso-occlusive crisis incidence in sickle cell disease: HIBISCUS 2 week 52 results. BRITISH JOURNAL OF HAEMATOLOGY. 2025.